Novo Nordisk’s Wegovy pill on par with injection, study shows; shares climb
PositiveFinancial Markets
A recent study has shown that Novo Nordisk's Wegovy pill is just as effective as its injection counterpart, leading to a significant rise in the company's shares. This is great news for those seeking weight management solutions, as it offers a more convenient option without compromising on effectiveness. The findings could potentially expand the market for Wegovy, making it more accessible to individuals who prefer oral medication over injections.
— Curated by the World Pulse Now AI Editorial System